Alpha 2.0
Login Register
» Authors » M Boeckh

M Boeckh

Explore the profile of M Boeckh including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 70
Citations 1899
Followers 0
Related Specialties
Infectious Diseases
General Surgery
Hematology
Top 10 Co-Authors
R A Bowden
L Corey
H Lode
D Myerson
A P Limaye
G Hoffken
P Koeppe
T Stevens-Ayers
W Leisenring
T Gooley
Published In
Blood
Bone Marrow Transplant
Transpl Infect Dis
J Infect Dis
Clin Infect Dis
Affiliations
Soon will be listed here.
Recent Articles
1.
Incidence and outcomes of bloodstream infections among hematopoietic cell transplant recipients from species commonly reported to be in over-the-counter probiotic formulations
Cohen S, Woodfield M, Boyle N, Stednick Z, Boeckh M, Pergam S
Transpl Infect Dis . 2016 Aug; 18(5):699-705. PMID: 27501401
Background: Probiotic supplementation has been promoted for numerous health conditions; however, safety in immunosuppressed patients is unknown. We evaluated bloodstream infections (BSIs) caused by common probiotic organisms in hematopoietic cell...
2.
Impact of early CMV reactivation in cord blood stem cell recipients in the current era
Ramanathan M, Teira P, Battiwalla M, Barrett J, Ahn K, Chen M, et al.
Bone Marrow Transplant . 2016 Apr; 51(8):1113-20. PMID: 27042847
Several studies have reported an association between CMV reactivation and a decreased incidence of relapse for AML after adult donor allogeneic hematopoietic cell transplantation (HCT). Limited data, however, are available...
3.
Sensitivity of blood and tissue diagnostics for gastrointestinal cytomegalovirus disease in solid organ transplant recipients
Fisher C, Alexander J, Bhattacharya R, Rakita R, Kirby K, Boeckh M, et al.
Transpl Infect Dis . 2016 Mar; 18(3):372-80. PMID: 27004439
Background: Gastrointestinal (GI) cytomegalovirus (CMV) disease is the most common manifestation of tissue-invasive CMV infection in solid organ transplant (SOT) recipients, but the diagnostic yields of blood and tissue testing...
4.
Human herpesvirus 6B reactivation and delirium are frequent and associated events after cord blood transplantation
Hill J, Boeckh M, Leisenring W, Xie H, Adler A, Huang M, et al.
Bone Marrow Transplant . 2015 Jun; 50(10):1348-51. PMID: 26121112
Human herpesvirus 6B (HHV-6B) frequently reactivates after cord blood transplantation (CBT). We previously reported an association between HHV-6B reactivation and delirium after hematopoietic cell transplantation. In this prospective study, 35...
5.
The association between donor and recipient statin use and infections after allogeneic hematopoietic cell transplantation
Seo S, Boeckh M, Storer B, Schubert M, Rotta M, Sandmaier B, et al.
Bone Marrow Transplant . 2015 Jan; 50(3):444-8. PMID: 25599167
Recent studies have reported that statin use may be associated with improved outcomes in patients with sepsis or respiratory viral infections. In the setting of allogeneic hematopoietic cell transplantation (HCT),...
6.
Parainfluenza virus type 3 Ab in allogeneic hematopoietic cell transplant recipients: factors influencing post-transplant Ab titers and associated outcomes
Seo S, Xie H, Karron R, Thumar B, Englund J, Leisenring W, et al.
Bone Marrow Transplant . 2014 Jul; 49(9):1205-11. PMID: 24978141
Parainfluenza virus type 3 (PIV-3) can cause severe respiratory illness among hematopoietic cell transplantation (HCT) recipients. Factors associated with PIV-3-specific Ab level, and the association between PIV-3 Ab levels and...
7.
Independent contribution of bronchoalveolar lavage and serum galactomannan in the diagnosis of invasive pulmonary aspergillosis
Fisher C, Stevens A, Leisenring W, Pergam S, Boeckh M, Hohl T
Transpl Infect Dis . 2014 Apr; 16(3):505-10. PMID: 24725139
The optimal combination of galactomannan index (GMI) testing for the diagnosis of invasive pulmonary aspergillosis (IPA) remains unclear. For diagnostic approaches that are triggered by clinical signs and symptoms in...
8.
DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient
Drozd D, Limaye A, Moss R, SANDERS R, Hansen C, Edelman J, et al.
Transpl Infect Dis . 2013 Jan; 15(1):E28-32. PMID: 23279859
Parainfluenza virus (PIV) may cause life-threatening pneumonia in lung transplant patients and there are no proven effective therapies. We report the use of inhaled DAS181, a novel sialidase fusion protein,...
9.
Cytomegalovirus infection and ganciclovir resistance caused by UL97 mutations in pediatric transplant recipients
Kim Y, Boeckh M, Cook L, Stempel H, Jerome K, Boucek Jr R, et al.
Transpl Infect Dis . 2012 Dec; 14(6):611-7. PMID: 23198963
Background: Cytomegalovirus (CMV) infection may cause serious disease after hematopoietic cell transplantation (HCT) and solid organ transplantation (SOT), but few reports describe ganciclovir (GCV) resistance in pediatric patients. Objectives: This...
10.
Risk factors for late-onset cytomegalovirus disease in donor seropositive/recipient seronegative kidney transplant recipients who receive antiviral prophylaxis
Boudreault A, Xie H, Rakita R, Scott J, Davis C, Boeckh M, et al.
Transpl Infect Dis . 2011 Mar; 13(3):244-9. PMID: 21414119
Background: Cytomegalovirus (CMV) disease occurs frequently after cessation of antiviral prophylaxis in CMV-seronegative kidney transplant recipients from seropositive donors (D+R-), and the risk factors are incompletely defined. Method: We retrospectively...